A Smart, "Always -On" Health Monitoring System
1 other identifier
observational
38
1 country
1
Brief Summary
This is a pilot study is to test a wireless, skin-sensor device against current technology in the NICU to monitor vitals
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 9, 2016
CompletedFirst Posted
Study publicly available on registry
August 12, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2021
CompletedJune 14, 2022
June 1, 2022
3.5 years
August 9, 2016
June 12, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation of vital parameters against current technology
15 min, 3 hours, 24 hours, 1 week
Secondary Outcomes (1)
Adverse events from wireless monitoring sensor assessed through Neonatal Skin Condition Score (NSCS)-sub-study only
24 hours, 1 week
Study Arms (9)
2 infants (ages 1-6mo) non-NICU setting
10 babies (full term, ages 37-42 weeks)
5 babies (premature, ages 34-37 weeks)
5 babies (premature, ages 31-34 weeks)
5 babies (premature, ages 28-31 weeks)
5 babies (premature, ages 25-28 weeks)
5 babies (premature, ages 23-25 weeks)
30 babies (any gestational age under 6 months)
25 neonates (ages 24-29 weeks for sub-study)
Interventions
Wireless vitals monitor
Eligibility Criteria
Up to 110 premature babies in the Lurie Children's Hospital and Prentice Women's Hospital NICU within 1 week of birth that fall into one of the listed cohorts, fit inclusion and exclusion criteria
You may qualify if:
- Neonates in different age cohorts from ages 25 weeks gestational age to fullterm infants or infants up to 6 months of age, selected with assistance of NICU staff
- Currently in NICU and requiring monitoring for heart rate, ECG, respiratory rate, temperature, and pulse oximetry
- Parents able to understand and provide informed consent for study
- Infants enrolled in the Pre-Vent study (sub-study only)
You may not qualify if:
- Over 6 months of age
- Hemodynamic or other instability precluding testing of new monitoring with concurrent standards
- Infants at imminent risk of death and neonates with a skin abnormality that precludes assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lurie Children's Hospital
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amy Paller, MD
Northwestern University, Lurie Children's Hospital Department of Dermatology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor in Dermatology and Pediatrics
Study Record Dates
First Submitted
August 9, 2016
First Posted
August 12, 2016
Study Start
March 1, 2016
Primary Completion
August 31, 2019
Study Completion
November 10, 2021
Last Updated
June 14, 2022
Record last verified: 2022-06